EUVIMEDEUVIMED entdecken
Crossref

Tocovid Attenuated Oxidative Stress and Cognitive Decline by Inhibiting Amyloid-β-Induced NOX2 Activation in Alzheimer’s Disease Mice

Zhihong Bian, Haibo Yu, Xinran Hu, Yuting Bian, Hongming Sun, Koh Tadokoro, Mami Takemoto, Taijun Yunoki, Yumiko Nakano, Yusuke Fukui, Ryuta Morihara, Koji Abe und 1 weitere

Journal of Alzheimer's Disease · 2024

DOI: 10.3233/jad-220761 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2024. Verfasst von Zhihong Bian und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Kita-ku, Okayama, Japan. Hauptthemen laut MEDLINE: Alzheimer Disease, NADPH Oxidase 2, Oxidative Stress, Mice, Transgenic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

NADPH oxidase 2 (NOX2) is an important source of reactive oxygen species (ROS). Activated NOX2 may contribute to Alzheimer’s disease (AD). Our previous studies showed that a novel vitamin E mixture, Tocovid, had potential neuroprotective effects in a stroke mice model and an AD cell model.

Objective

The aim of this study was two-fold: to assess whether long-term Tocovid treatment can regulate NOX2, and the therapeutic effects of long-term administration of Tocovid to an AD mice model.

Methods

Therapeutic effects of long-term administration of Tocovid (200 mg/kg /day) on an Aβ-overexpressed transgenic AD mice model (APP23, n = 8) was investigated. The therapeutic effect of Tocovid in 16-month-old mice compared with the no-treatment APP23 group (n = 9) was assessed.

Results

Tocovid treatment strongly improved motor and memory deficits of APP23 mice by attenuating NOX2 expression, oxidative stress, neuroinflammation, neurovascular unit dysfunction, synaptic alteration, and Aβ deposition after 16 months.

Conclusion

These findings suggest that NOX2 is a potential target in AD pathology. Long-term administration of Tocovid may be a promising candidate for AD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNADPH Oxidase 2Oxidative StressMice, TransgenicAmyloid beta-PeptidesCognitive DysfunctionDisease Models, AnimalAnimalsMiceMaleMice, Inbred C57BLNeuroprotective Agents

Stichwörter der Autor:innen

Alzheimer’s diseaseNOX2Tocovidcerebral amyloid angiopathyoxidative stress

Substanzen

NADPH Oxidase 2Amyloid beta-PeptidesCybb protein, mouseNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Kita-ku, Okayama, Japan.
  • National Center Hospital, National Center of Neurology and Psychiatry, Kodaira-shi, Tokyo, Japan.

Zitieren

APA

Bian, Z., Yu, H., Hu, X., Bian, Y., Sun, H., Tadokoro, K., Takemoto, M., Yunoki, T., Nakano, Y., Fukui, Y., Morihara, R., Abe, K., & Yamashita, T. (2024). Tocovid Attenuated Oxidative Stress and Cognitive Decline by Inhibiting Amyloid-β-Induced NOX2 Activation in Alzheimer’s Disease Mice. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-220761

Vancouver

Bian Z, Yu H, Hu X, Bian Y, Sun H, Tadokoro K, et al. Tocovid Attenuated Oxidative Stress and Cognitive Decline by Inhibiting Amyloid-β-Induced NOX2 Activation in Alzheimer’s Disease Mice. Journal of Alzheimer's Disease. 2024. doi:10.3233/jad-220761

BibTeX
@article{Bian2024,
  author = {Bian, Zhihong and Yu, Haibo and Hu, Xinran and Bian, Yuting and Sun, Hongming and Tadokoro, Koh and Takemoto, Mami and Yunoki, Taijun and Nakano, Yumiko and Fukui, Yusuke and Morihara, Ryuta and Abe, Koji and Yamashita, Toru},
  title = {Tocovid Attenuated Oxidative Stress and Cognitive Decline by Inhibiting Amyloid-β-Induced NOX2 Activation in Alzheimer’s Disease Mice},
  journal = {Journal of Alzheimer's Disease},
  year = {2024},
  doi = {10.3233/jad-220761}
}
Kostenlos starten →